Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MMultiQureWAR:MQR +11.95%19 Market Cap is zł40.16 Mil as of Aug. 11, 2026. GuruFocus rates WAR:MQR with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 1,420 Biotechnology companies, MMultiQure ranks worse than 83.8% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MMultiQure's share price for the quarter that ended in Mar. 2026 was zł2.65. MMultiQure's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 12.25 Mil. Therefore, MMultiQure's market cap for the quarter that ended in Mar. 2026 was zł32.45 Mil.
MMultiQure's quarterly market cap
declined
from Sep. 2025 (zł43.04 Mil) to Dec. 2025 (zł40.36 Mil) and
declined
from Dec. 2025 (zł40.36 Mil) to Mar. 2026 (zł32.45 Mil).
MMultiQure's annual market cap
increased
from Dec. 2023 (zł42.07 Mil) to Dec. 2024 (zł64.47 Mil) but then
declined
from Dec. 2024 (zł64.47 Mil) to Dec. 2025 (zł40.36 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MMultiQure's Enterprise Value for Today is zł55.59 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MMultiQure Market Cap Related Terms
MMultiQure Market Cap Historical Data
* Premium members only.
The historical data trend for MMultiQure's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:MQR vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, MMultiQure's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MMultiQure Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MMultiQure's Market Cap distribution charts can be found below:
* The bar in red indicates where MMultiQure's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
MMultiQure's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MMultiQure (WAR:MQR) has a Market Cap of zł40.16 Mil as of Aug. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MMultiQure and its competitors. According to the industry distribution chart, MMultiQure ranks #1190 out of 1420 companies in the Biotechnology industry, placing it in the top 83.8%.
Is MMultiQure's Market Cap too high?
MMultiQure's current Market Cap is zł40.16 Mil. Based on the distribution chart, MMultiQure ranks #1190 out of 1420 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MMultiQure has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does MMultiQure's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MMultiQure ranks #1190 out of 1420 companies for Market Cap. This places MMultiQure in the lower half of its industry. The industry median Market Cap is 116.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 116.29, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MMultiQure and its competitors. For the Biotechnology industry, the median Market Cap is 116.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MMultiQure's current Market Cap is zł40.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MMultiQure stock overvalued right now?
MMultiQure (WAR:MQR) has a current Market Cap of zł40.16 Mil. The current Market Cap is zł40.16 Mil. MMultiQure's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MMultiQure (WAR:MQR), the current Market Cap is zł40.16 Mil as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.
19GF Score
Get the complete analysis for WAR:MQR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MQR has been successfully added to your 
